Together we will beat cancer

Donate

How UK researchers commercialised CD25 as an immunotherapy drug target

Cancer Research UK scientists in collaboration with Roche have developed a new antibody that can target CD25 and harness the immune system against cancer.

Read More

PARP inhibitors: Halting cancer by halting DNA repair

How researchers supported by Cancer Research UK pioneered the development of PARP inhibitors.

Read More